With training ranging from India to UConn, to New York Presbyterian, Setu Vora is a physician leader with a personal mission to practice, prevent, and promote.
He has rich clinical exposure and scientific research experience that spans working in critical care units in India that included patients with falciparum malaria, tetanus, and cobra envenomations; to managing a leptospirosis epidemic in the field; to being awarded the NIH Excellence in Gene Therapy during his work on SARS corona virus vaccine development at the Crystal Lab. He was in the pioneer group that piloted the full scale implementation of eICU at a tertiary academic hospital in New York.
Currently he is working to improve the health of a Tribal Nation by supporting leaders to improve care delivery, community health, and company growth, on the foundation of a culture of resilience and innovation.
With a strategic and tactical role as a Chief Medical Officer, Dr. Vora overseas healthcare services, population health, occupational and employee health, Independent TPA, Pharmacy and PBM, federal grants, self funded, self insured health plans design and management, digital transformation, SDOH interventions, and health engagement at MPTN.
His current ABIM clinical board certifications are in the specialties of Internal Medicine, Pulmonary Diseases, Critical Care Medicine, and Sleep Medicine.”